✨
AI Summary
- Differentiated immune checkpoint inhibitor adverse events (IrAEs) from other conditions.
- Reviewed pneumonitis, colitis, dermatitis, and endocrinopathies from ICIs.
- Provided practical approaches to managing ICI-related toxicities.